Table 1 Characteristics of the study population according to the Pro12Ala genotype
Pro/Pro (N =212) | ProAla (N = 44) | |
|---|---|---|
Males (%) | 119 (56.1) | 23 (52.3) |
Age (years) | 60.9 ± 4.1 | 60.3 ± 5.7 |
BMI (Kg/m2) | 29.4 ± 4.0 | 29.6 ± 4.5 |
HB1Ac (%) | 7.0 ± 1.5 | 6.9 ± 0.9 |
Systolic BP (mmHg) | 135.3 ± 18.6 | 133.0 ± 27.6 |
Diastolic BP (mmHg) | 78.4 ± 8.3 | 78.7 ± 15.9 |
Diabetes duration (years) | 7.4 ± 6.3 | 8. 2 ± 7.3 |
Smokers (%) | 49 (23.1) | 11 (25) |
With Rethinopathy (%) | 49 (23.1) | 12 (27.3) |
Treated with diet (%) | 20 (9.6) | 5 (11.9) |
Treated with oral agents (%) | 138 (66) | 29 (69.1) |
Treated with insulin (%) | 51 (24.4) | 8 (19) |
Treated with ACE or ARB (%) | 155 (73.1) | 29 (65.9) |
Treated with Statins (%) | 131 (61.8) | 21 (47.7) |
Microalbuminuria (%) | 62 (29.2) | 10 (22.7) |
Macroalbuminuria (%) | 8 (3.8) | 2 (4.5) |
GFR < 60 ml/min/ 1.73 m2 (%) | 14 (6.7) | 3 (7) |